Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0004 USD | 0.00% |
|
0.00% | 0.00% |
2013 | Sino Bioenergy Corp. Announces Management Changes | CI |
2013 | Sino Bioenergy Corp. cancelled the acquisition of 51% in Noble Success Limited. | CI |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 2.136 |
Enterprise Value (EV) 1 | 2.16 |
P/E ratio | -6.37 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | - |
EV / FCF | - |
FCF Yield | - |
Price to Book | -6.37 x |
Nbr of stocks (in thousands) | 7,11,916 |
Reference price 2 | 0.003000 |
Announcement Date | 01/02/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 |
---|---|
Net sales | - |
EBITDA | - |
EBIT 1 | -0.0167 |
Operating Margin | - |
Earnings before Tax (EBT) 1 | -0.0242 |
Net income 1 | -0.0242 |
Net margin | - |
EPS 2 | -0.000471 |
Free Cash Flow | - |
FCF margin | - |
FCF Conversion (EBITDA) | - |
FCF Conversion (Net income) | - |
Dividend per Share | - |
Announcement Date | 01/02/24 |
Balance Sheet Analysis
Fiscal Period: December | 2022 |
---|---|
Net Debt 1 | 0.02 |
Net Cash position 1 | - |
Leverage (Debt/EBITDA) | - |
Free Cash Flow | - |
ROE (net income / shareholders' equity) | - |
ROA (Net income/ Total Assets) | - |
Assets 1 | - |
Book Value Per Share 2 | -0 |
Cash Flow per Share 2 | 0 |
Capex | - |
Capex / Sales | - |
Announcement Date | 01/02/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 20.5T | |
-5.12% | 167.37Cr | |
-.--% | 21Cr | |
-10.66% | 19Cr |
- Stock Market
- Equities
- SFBE Stock
- Financials Sino Bioenergy Corp.